The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors, also called gliflozins or flozins, are a class of drugs that have been increasingly used in the management of type 2 diabetes mellitus (T2DM) due to their glucose-lowering, cardiovascular (CV), and renal positive effects. However, recent studies suggest that SGLT-2 inhibitors might also have a ket...
Alternative Titles
Full title
The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_40db6ecb3fb842989bffded2250aecf0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_40db6ecb3fb842989bffded2250aecf0
Other Identifiers
ISSN
2308-3425
E-ISSN
2308-3425
DOI
10.3390/jcdd10110465
